CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Business Wire
Concludes Distribution Agreement with Gore® for VIABIL® in the United States and Canada, Effective January 1, 2026Announces Intent to Exit Remaining Products in its Gastroenterology Product PortfolioReaffirms 2025 Revenue and EPS Guidance LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets—minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft tissue repair.“Today’s announcement reflects a positive step in our strategic portfolio review and our commitment to focus on areas where CONMED can lead in innovation and deliver the greatest impact— minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “By c
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED (NYSE:CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $58.00 to $52.00. They now have a "neutral" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its price target lowered by analysts at Wells Fargo & Company from $57.00 to $47.00. They now have an "equal weight" rating on the stock.MarketBeat
- Conmed Corp (CNMD) Q3 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Challenges [Yahoo! Finance]Yahoo! Finance
- CONMED Corporation Announces Third Quarter 2025 Financial ResultsBusiness Wire
CNMD
Earnings
- 11/5/25 - Beat
CNMD
Sec Filings
- 12/5/25 - Form 8-K
- 11/24/25 - Form 4
- 11/21/25 - Form 4
- CNMD's page on the SEC website